Healthcare ❯ Pharmaceuticals ❯ Drug Development

Obesity Treatments

GLP-1 Drugs GLP-1 Medications Diabetes Treatments

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Soaring GLP‑1 sales, plus expectations for an oral obesity pill, lifted the drugmaker to the milestone.

Eli Lilly Briefly Hits $1 Trillion, First Drugmaker to Reach the Milestone

Lilly’s Oral GLP-1 Pill Meets Phase 3 Goals, Shares Rebound